Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Clicks: 360
ID: 270484
2021
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
8.7
/100
29 views
29 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
European Myeloma Network and Janssen Research and Development.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (8 words).
Try re-searching for a better abstract.
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.